Shanghai Nianxing Industrial Co., Ltd
China
Product Name: MPI-0479605
Price:
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang

ShangHai DC Chemicals Co.,Ltd
China
Product Name: MPI-0479605
Price: ￥Inquiry/1g
Purity: 98.9%
Stocking Period: 1 Day
Contact: Tony Lai

DC Chemicals Limited
China
Product Name: MPI-0479605
Price: $550.0/100mg $1000.0/250mg $1900.0/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: MPI-0479605
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

1246529-32-7

1246529-32-7 structure

1246529-32-7 structure

Name: MPI-0479605
Chemical Name: 9H-Purine-2,6-diamine, N6-cyclohexyl-N2-[2-methyl-4-(4-morpholinyl)phenyl]-
CAS Number: 1246529-32-7
Molecular Formula: C₂₂H₂₉N₇O
Molecular Weight: 407.512
Catalog: Biochemical Inhibitor Cytoskeletal Signaling Kinesin inhibitor
Create Date: 2018-12-11 09:15:04
Modify Date: 2024-01-02 16:48:05
MPI-0479605 is a potent and selective ATP-competitive inhibitor of Mps1, with an IC50 of 1.8 nM.

Name	9H-Purine-2,6-diamine, N6-cyclohexyl-N2-[2-methyl-4-(4-morpholinyl)phenyl]-
Synonyms	N-Cyclohexyl-N-[2-methyl-4-(4-morpholinyl)phenyl]-3H-purine-2,6-diamine mpi-0479605 9H-Purine-2,6-diamine, N-cyclohexyl-N-[2-methyl-4-(4-morpholinyl)phenyl]-

Description	MPI-0479605 is a potent and selective ATP-competitive inhibitor of Mps1, with an IC50 of 1.8 nM.
Related Catalog	Signaling Pathways >> Cell Cycle/DNA Damage >> Mps1 Signaling Pathways >> Cytoskeleton >> Mps1 Research Areas >> Cancer
Target	Mps1:1.8 nM (IC50) ALK:0.26 μM (IC50) B-RAF:3.2 μM (IC50) ERK2:3.9 μM (IC50) FAK1:2.7 μM (IC50) FER:0.59 μM (IC50) FLT3:0.08 μM (IC50) INSR:0.38 μM (IC50) JNK1:0.11 μM (IC50) PLK4:3.3 μM (IC50) STK33:1.1 μM (IC50)
In Vitro	MPI-0479605 is a potent and selective ATP-competitive inhibitor of Mps1, with an IC50 of 1.8 nM. MPI-0479605 (0.1-10 μM) reduces cell viability of HCT-116 cells in a dose-dependent manner. MPI-0479605 shows severe defects in the ability to align chromosomes at the metaphase plate, but causes complete cytokinesis[1].
In Vivo	MPI-0479605 (30 mg/kg daily or 150 mg/kg every fourth day (Q4D), i.p.) inhibits tumor growth by 49% and 74 % in HCT-116 xenografts. However, MPI-0479605 does not show inhibitory activity via daily dosing on the Colo-205 xenografts, and dosing every four days causes 63% tumor growth inhibition (TGI)[1].
Animal Admin	HCT-116 or Colo-205 cells are transplanted subcutaneously into the flanks of nude (nu+/nu+) mice and compound (MPI-0479605) treatment is initiated when tumor masses reaches an average size of 100 mm3. MPI-0479605 is formulated in 5% dimethylacetamide (DMA)/12% ethanol/40% PEG-300, ispinesib is formulated in 2% cremaphor/2% DMA, and 5-fluorouracil is formulated in 2% sodium bicarbonate. Tumor volume is measured using vernier calipers and tumor growth inhibition (TGI) is calculated as: %TGI= 100-100(change in median tumor volume of treated)/(change in median tumor volume control)[1].
References	[1]. Tardif KD, et al. Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1. Mol Cancer Ther. 2011 Dec;10(12):2267-2275.

Density	1.3±0.1 g/cm3
Molecular Formula	C₂₂H₂₉N₇O
Molecular Weight	407.512
Exact Mass	407.243347
PSA	90.99000
LogP	1.69
Index of Refraction	1.700
Storage condition	-20℃